Oxidative stress in malignant and non-malignant phase hypertension
- 1 May 2002
- journal article
- research article
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 16 (5), 333-336
- https://doi.org/10.1038/sj.jhh.1001386
Abstract
Malignant hypertension (MHT) is a rare and severe form of hypertension characterised by arteriolar necrosis and severe vascular damage, leading to stroke, myocardial infarction and death. We hypothesised that in addition to endothelial damage, MHT may be associated with increased oxidative stress. Lipid hydroperoxides (LHP, an index of oxidative damage) and plasma von Willebrand factor (vWf, an index of endothelial damage/dysfunction) were measured in 16 patients with MHT and compared with 16 non-malignant essential hypertensives and 32 normotensive controls. vWf was greater in MHT (mean 117 iU/dL) than in non-malignant hypertensives (97 iU/dL) or normotensive controls (100 iU/dL) (ANOVA P = 0.017). However, although LHP were greater in MHT (mean 10.6 μmol/L) than in normotensives (4.5 μmol/L, P < 0.001), the levels in MHT were similar to those in non-malignant hypertension (12.3 μmol/L). In conclusion endothelial damage (raised vWf) was more evident in MHT compared with both normotensive controls and with non-malignant hypertension, whilst oxidative stress (raised LHP) was increased to a similar extent in both hypertension groups when compared with normotensive controls. These observations raise the possibility abnormal oxidative stress is probably not the mechanism responsible for the endothelial damage seen in malignant phase hypertension.Keywords
This publication has 10 references indexed in Scilit:
- Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertensionJournal Of Hypertension, 1999
- The endothelium in atherothrombotic diseasePublished by Wolters Kluwer Health ,1998
- Relation of Endothelium, Thrombogenesis, and Hemorheology in Systemic Hypertension to Ethnicity and Left Ventricular HypertrophyThe American Journal of Cardiology, 1997
- The role of rheological and haemostatic factors in hypertensionJournal of Human Hypertension, 1997
- Complications and survival of 315 patients with malignant-phase hypertensionJournal Of Hypertension, 1995
- The failure of malignant hypertension to declineJournal Of Hypertension, 1994
- Measurement of Plasma Hydroperoxide Concentrations by the Ferrous Oxidation-Xylenol Orange Assay in Conjunction with TriphenylphosphineAnalytical Biochemistry, 1994
- Lack of difference between malignant and accelerated hypertension.BMJ, 1986
- Hypertension--Treated and UntreatedBMJ, 1959
- Some Different Types Of Essential HypertensionThe American Journal of the Medical Sciences, 1939